Highlights Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
8.45 ^USD	+2.80%		+25.19%	-33.73%

Jul. 16	Truist Raises Price Target on Treace Medical Concepts to $9 From $7, Maintains Hold Rating	MT
Jul. 15	Morgan Stanley Raises Price Target on Treace Medical Concepts to $8 From $5.50, Keeps Equalweight Rating	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

North American Morning Briefing : The "Everything -2-	May. 17	DJ
Top Midday Decliners	May. 08	MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures	May. 08	MT
Top Premarket Decliners	May. 08	MT
Treace Medical Concepts Falls 57% Premarket After Revising 2024 Sales Outlook to $201-$211 Million From $220-$225 Million	May. 08	MT
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q1 Revenue $51.1M, vs. Street Est of $49.1M	May. 07	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Treace Medical Concepts, Inc. Revises Earnings Guidance for the Full-Year 2024	May. 07	CI
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	Mar. 25	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	Feb. 27	MT
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	Feb. 27	CI
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	Feb. 02	CI
Treace Medical Concepts, Inc. Updates Preliminary Revenue Guidance for the Fourth Quarter and Full Year of 2023	Jan. 08	CI
Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook	Nov. 10	MT
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Posts Q3 Revenue $40.8M, vs. Street Est of $42.1M	Nov. 09	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023	Nov. 09	CI
Treace Medical Concepts, Inc. Highlights New Product Innovations and Updated Align3d Clinical Study Data At the American Orthopaedic Foot & Ankle Society Annual Meeting 2023	23-09-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Highlights

Filters